Quantum Biopharma says it is closer to initiating a Phase 2 clinical trial — one involving people living with multiple sclerosis (MS) — to test its experimental therapy Lucid-MS after […] The post With new data, Quantum moves closer to launching trial of Lucid-MS appeared first on Multiple Sclerosis News Today.
